Idorsia Ltd. (IDRSF)
5.38
0.00 (0.00%)
USD |
OTCM |
Oct 15, 16:00
Idorsia SG&A Expense (TTM) : 264.55M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 264.55M |
| March 31, 2026 | 266.83M |
| December 31, 2025 | 262.59M |
| September 30, 2025 | 263.66M |
| June 30, 2025 | 258.67M |
| March 31, 2025 | 274.32M |
| December 31, 2024 | 293.58M |
| September 30, 2024 | 303.98M |
| June 30, 2024 | 316.41M |
| March 31, 2024 | 370.30M |
| December 31, 2023 | 419.21M |
| September 30, 2023 | 468.13M |
| June 30, 2023 | 533.26M |
| March 31, 2023 | 532.53M |
| December 31, 2022 | 513.23M |
| September 30, 2022 | 487.00M |
| June 30, 2022 | 403.88M |
| March 31, 2022 | 316.18M |
| December 31, 2021 | 241.03M |
| Date | Value |
|---|---|
| September 30, 2021 | 168.02M |
| June 30, 2021 | 137.48M |
| March 31, 2021 | 113.33M |
| December 31, 2020 | 98.88M |
| September 30, 2020 | 79.56M |
| June 30, 2020 | 71.02M |
| March 31, 2020 | 68.91M |
| December 31, 2019 | 66.86M |
| September 30, 2019 | 63.69M |
| June 30, 2019 | 63.94M |
| March 31, 2019 | 62.95M |
| December 31, 2018 | 61.93M |
| September 30, 2018 | 61.63M |
| June 30, 2018 | 59.38M |
| March 31, 2018 | 43.80M |
| December 31, 2017 | 49.88M |
| September 30, 2017 | 33.94M |
| June 30, 2017 | 20.57M |
| March 31, 2017 | 20.57M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Basilea Pharmaceutica AG | 45.60M |
| Santhera Pharmaceuticals Holding AG | 18.92M |
| BeOne Medicines Ltd. | 2.238B |
| AC Immune SA | 19.51M |
| CRISPR Therapeutics AG | 70.07M |